(18)F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging

Prostate-specific membrane antigen (PSMA)-targeted PET imaging for prostate cancer with (68)Ga-labeled compounds has rapidly become adopted as part of routine clinical care in many parts of the world. However, recent years have witnessed the start of a shift from (68)Ga- to (18)F-labeled PSMA-target...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Theranostics
Autors principals: Werner, Rudolf A., Derlin, Thorsten, Lapa, Constantin, Sheikbahaei, Sara, Higuchi, Takahiro, Giesel, Frederik L., Behr, Spencer, Drzezga, Alexander, Kimura, Hiroyuki, Buck, Andreas K., Bengel, Frank M., Pomper, Martin G., Gorin, Michael A., Rowe, Steven P.
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6929634/
https://ncbi.nlm.nih.gov/pubmed/31903102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.37894
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars